Kazuyoshi Aso

1.1k total citations
29 papers, 610 citations indexed

About

Kazuyoshi Aso is a scholar working on Molecular Biology, Behavioral Neuroscience and Cellular and Molecular Neuroscience. According to data from OpenAlex, Kazuyoshi Aso has authored 29 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Behavioral Neuroscience and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Kazuyoshi Aso's work include Stress Responses and Cortisol (7 papers), Neuroscience and Neuropharmacology Research (4 papers) and Biochemical and Molecular Research (4 papers). Kazuyoshi Aso is often cited by papers focused on Stress Responses and Cortisol (7 papers), Neuroscience and Neuropharmacology Research (4 papers) and Biochemical and Molecular Research (4 papers). Kazuyoshi Aso collaborates with scholars based in Japan, United States and China. Kazuyoshi Aso's co-authors include Yasutomi Asano, Toshihiro Imaeda, Rei Okamoto, Jumpei Aida, Katherine Rothamel, J. Fraser Glickman, Antonio N. Luz, Seth A. Reasoner, Pu Gao and Jessica Vincent and has published in prestigious journals such as Nature Communications, Blood and PLoS ONE.

In The Last Decade

Kazuyoshi Aso

29 papers receiving 602 citations

Peers

Countries citing papers authored by Kazuyoshi Aso

Since Specialization

Citations

This map shows the geographic impact of Kazuyoshi Aso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuyoshi Aso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuyoshi Aso more than expected).

Fields of papers citing papers by Kazuyoshi Aso

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuyoshi Aso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuyoshi Aso. The network helps show where Kazuyoshi Aso may publish in the future.

Co-authorship network of co-authors of Kazuyoshi Aso

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuyoshi Aso. A scholar is included among the top collaborators of Kazuyoshi Aso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuyoshi Aso. Kazuyoshi Aso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Design, Synthesis, and Optimization of Macrocyclic Peptides as Species-Selective Antimalaria Proteasome Inhibitors 2022 ·Journal of Medicinal Chemistry ·Hao Zhang, John D. Ginn, Wenhu Zhan, (unknown), (unknown), (unknown), Rei Okamoto, (unknown), Toshihiro Imaeda, Ryoma Hara, (unknown), Mayako Michino, Jérémie Vendôme, Thijs Beuming, Kenjiro Sato, Kazuyoshi Aso, Peter T. Meinke, Carl Nathan, Laura A. Kirkman, Gang Lin	16
2	Whole Cell Active Inhibitors of Mycobacterial Lipoamide Dehydrogenase Afford Selectivity over the Human Enzyme through Tight Binding Interactions 2021 ·ACS Infectious Diseases ·John D. Ginn, Xiuju Jiang, (unknown), Mayako Michino, David J. Huggins, (unknown), Robert S. Jansen, Kyu Y. Rhee, (unknown), Christopher D. Lima, Nigel J. Liverton, Toshihiro Imaeda, Rei Okamoto, Takanobu Kuroita, Kazuyoshi Aso, Andrew W. Stamford, Michael A. Foley, Peter T. Meinke, Carl Nathan, Ruslana Bryk	5
3	Discovery of 1,2,3,4-tetrahydropyrimido[1,2-a]benzimidazoles as novel class of corticotropin releasing factor 1 receptor antagonists 2018 ·Bioorganic & Medicinal Chemistry ·(unknown), (unknown), Takafumi Takai, Yasutaka Hoashi, (unknown), Masaki Seto, Minoru Nakamura, Katsumi Kobayashi, (unknown), Maiko Tanaka, Naoyuki Kanzaki, Yohei Kosugi, Takahiko Yano, Kazuyoshi Aso	28
4	Identification of a novel series of potent and selective CCR6 inhibitors as biological probes 2018 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), (unknown), Kyoko Yoshikawa, (unknown), Haruhiko Kuno, (unknown), Kazuyoshi Aso	13
5	Small molecule inhibition of cGAS reduces interferon expression in primary macrophages from autoimmune mice 2017 ·Nature Communications ·Jessica Vincent, Carolina Adura, Pu Gao, Antonio N. Luz, Lodoe Lama, Yasutomi Asano, Rei Okamoto, Toshihiro Imaeda, Jumpei Aida, Katherine Rothamel, Tasos Gogakos, Joshua Steinberg, Seth A. Reasoner, Kazuyoshi Aso, Thomas Tuschl, Dinshaw J. Patel, J. Fraser Glickman, Manuel Ascano	261
6	Characterization of CRF 1 receptor antagonists with differential peripheral vs central actions in CRF challenge in rats 2017 ·Peptides ·Maiko Tanaka, (unknown), (unknown), (unknown), (unknown), (unknown), Kazuyoshi Aso, Takahiko Yano, Keisuke Hirai	2
7	Design, synthesis, and pharmacological evaluation of 4-azolyl-benzamide derivatives as novel GPR52 agonists 2017 ·Bioorganic & Medicinal Chemistry ·(unknown), Y. ITO, Izumi Nomura, (unknown), Yūji Shimizu, Emi Kurimoto, Kazunobu Aoyama, Kazuyoshi Aso	16
8	Discovery of 4-chloro-2-(2,4-dichloro-6-methylphenoxy)-1-methyl-7-(pentan-3-yl)-1H-benzimidazole, a novel CRF1 receptor antagonist 2016 ·Bioorganic & Medicinal Chemistry ·(unknown), (unknown), Katsumi Kobayashi, (unknown), Yuji Ishichi, Naoyuki Kanzaki, Hideyuki Nakagawa, Teruaki Okuda, Yohei Kosugi, Takahiko Yano, (unknown), Maiko Tanaka, Kazuyoshi Aso	4
9	Adipose-Derived Mesenchymal Stem Cells Restore Impaired Mucosal Immune Responses in Aged Mice 2016 ·PLoS ONE ·Kazuyoshi Aso, (unknown), Kentaro Takagaki, Katsuyuki Oki, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Kenneth W. Beagley, Kohtaro Fujihashi	1
10	Discovery of a 7-arylaminobenzimidazole series as novel CRF1 receptor antagonists 2016 ·Bioorganic & Medicinal Chemistry ·(unknown), Masakuni Kori, (unknown), Takahiko Yano, (unknown), Maiko Tanaka, Naoyuki Kanzaki, (unknown), (unknown), Kazuyoshi Aso	3
11	A Molecular Mucosal Adjuvant To Enhance Immunity Against Pneumococcal Infection In The Elderly 2015 ·Immune Network ·Yoshiko Fukuyama, (unknown), Junichiro Ohori, (unknown), Kazuyoshi Aso, Keiko Fujihashi, David E. Briles, Jerry R. McGhee, Kohtaro Fujihashi	9
12	Potential Roles of CCR5+ CCR6+ Dendritic Cells Induced by Nasal Ovalbumin plus Flt3 Ligand Expressing Adenovirus for Mucosal IgA Responses 2013 ·PLoS ONE ·Yoshiko Fukuyama, Daisuke Tokuhara, Shinichi Sekine, Kazuyoshi Aso, Kosuke Kataoka, Julia Davydova, Masato Yamamoto, Rebekah S. Gilbert, (unknown), Keiko Fujihashi, Jun Kunisawa, Yoshikazu Yuki, Hiroshi Kiyono, Jerry R. McGhee, (unknown), (unknown)	8
13	Melanin-concentrating hormone receptor 1 antagonists: Synthesis, structure–activity relationship, docking studies, and biological evaluation of 2,3,4,5-tetrahydro-1H-3-benzazepine derivatives 2011 ·Bioorganic & Medicinal Chemistry ·(unknown), Masahiro Kamaura, (unknown), Kazuyoshi Aso, (unknown), (unknown), Kaoru Watanabe, (unknown), Michiko Tawada, (unknown), Shiro Takekawa, Koki Kato, Nobuhiro Suzuki, Yuji Ishihara	13
14	Discovery of pyrrolo[2,3-d]pyrimidin-4-ones as corticotropin-releasing factor 1 receptor antagonists with a carbonyl-based hydrogen bonding acceptor 2011 ·Bioorganic & Medicinal Chemistry Letters ·Kazuyoshi Aso, Katsumi Kobayashi, (unknown), Naoyuki Kanzaki, (unknown), Takahiko Yano	6
15	Discovery, synthesis and biological evaluation of isoquinolones as novel and highly selective JNK inhibitors (1) 2008 ·Bioorganic & Medicinal Chemistry ·Yasutomi Asano, Shuji Kitamura, (unknown), Kazuyoshi Aso, Hideki Igata, Tomoko Tamura, Tomohiro Kawamoto, Toshimasa Tanaka, Satoshi Sogabe, Shin-ichi Matsumoto, Masashi Yamaguchi, Hiroyuki Kimura, Fumio Itoh	24
16	Thyrotropin-producing pituitary adenoma associated with Graves' disease 2004 ·European Journal of Endocrinology ·Nobuyuki Koriyama, Mitsuhiro Nakazaki, Hiroshi Hashiguchi, Kazuyoshi Aso, Y. Ikeda, Takashi Kimura, (unknown), Hirofumi Hirano, Shoko Nakano, Chuwa Tei	19
17	Enzyme-inhibition system for identifying potential antimalarials that target highly drug-resistant mutants of Plasmodium falciparum dihydrofolate reductase 1998 ·Parasitology International ·Reynolds Brobey, Masahiro Iwakura, Fumio Itoh, Kazuyoshi Aso, Toshihiro Horii	4
18	Recombinant Plasmodium falciparum dihydrofolate reductase-based in vitro screen for antifolate antimalarials 1996 ·Molecular and Biochemical Parasitology ·Reynolds Brobey, Gen‐ichiro Sano, Fumio Itoh, Kazuyoshi Aso, Masatsugu Kimura, T. Mitamura, Toshihiro Horii	18
19	Synthesis and Antitumor Activity of Pyrrolo(2,3-d)pyrimidine Antifolates with a Bridge Chain Containing a Nitrogen Atom. 1995 ·Chemical and Pharmaceutical Bulletin ·Kazuyoshi Aso, (unknown), (unknown), Koichiro Ootsu, (unknown)	8
20	Evaluation Methods of Reliability on Copper Foil for Use In PCBs. 1995 ·(unknown), (unknown), Kazuyoshi Aso	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact